tiprankstipranks
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
US Market
Holding PRCT?
Track your performance easily

PROCEPT BioRobotics (PRCT) Earnings Dates, Call Summary & Reports

421 Followers

Earnings Data

Report Date
Mar 04, 2025
TBA Not Confirmed
Period Ending
2024 (Q4)
Consensus EPS Forecast
-0.34
Last Year’s EPS
-0.54
Same Quarter Last Year
Based on 8 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 08, 2022
|
% Change Since: 10.54%
|
Next Earnings Date:Nov 04, 2021
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, a successful new product launch, and high gross margins, indicating strong business momentum. However, operational challenges due to sales team training and macroeconomic factors like saline shortages and weather events have posed some challenges. The sentiment is positive, with a focus on continued growth and expansion opportunities.
Company Guidance
During the PROCEPT BioRobotics Q3 2024 earnings call, executives highlighted significant achievements and updated guidance metrics. The company reported a total revenue of $58.4 million, reflecting a 66% growth compared to the same quarter in 2023. The U.S. revenue reached $52.2 million with a 62% increase, while international revenue grew by 86%, notably driven by the UK market. They sold 45 robotic systems with an average selling price (ASP) of approximately $432,000, with 80% being the new HYDROS systems. The company's gross margin hit a record high of 63.2% due to the successful launch and higher ASPs of HYDROS. For 2024, the company adjusted its revenue guidance to a range between $222.5 million and $223 million, marking a 63% to 64% growth over 2023. They project selling around 186 robotic systems for the year, with an ASP in Q4 ranging from $420,000 to $430,000. The company also plans to sell approximately 9,950 handpieces in Q4, totaling around 33,500 for the year. Adjusted EBITDA loss is expected to be around $60 million, an improvement from initial guidance.
Strong Revenue Growth
Total revenue for Q3 2024 was $58.4 million, representing a 66% increase compared to Q3 2023. U.S. revenue grew by 62% while international revenue increased by 121%.
Successful Launch of HYDROS Robotic System
HYDROS system accounted for 80% of the 45 robotic systems sold in Q3. The launch has been met with positive feedback for its AI assist feature and streamlined setup process.
Record Gross Margin
Achieved an all-time high gross margin of 63.2% due to higher HYDROS system average selling prices.
FDA Breakthrough Device Designation
The FDA granted breakthrough device designation for a clinical trial of Aquablation therapy for prostate cancer, representing a significant milestone.
Positive Utilization Trends
U.S. handpiece and consumable revenue grew by 74% with a 79% increase in handpiece units, driven by an expanded installed base and increased utilization per account.
---

PROCEPT BioRobotics (PRCT) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PRCT Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 04, 20212021 (Q3)
-0.41 / -1.22
-0.276-342.03% (-0.94)
Mar 08, 20222021 (Q4)
-0.39 / -0.42
May 05, 20222022 (Q1)
-0.47 / -0.39
-0.295-32.20% (-0.10)
Aug 04, 20222022 (Q2)
-0.48 / -0.43
-0.41-4.88% (-0.02)
Nov 03, 20222022 (Q3)
-0.48 / -0.51
-1.2258.20% (+0.71)
Feb 28, 20232022 (Q4)
-0.54 / -0.63
-0.42-50.00% (-0.21)
Apr 27, 20232023 (Q1)
-0.58 / -0.63
-0.39-61.54% (-0.24)
Jul 27, 20232023 (Q2)
-0.57 / -0.56
-0.43-30.23% (-0.13)
Nov 01, 20232023 (Q3)
-0.53 / -0.51
-0.510.00% (0.00)
Feb 27, 20242023 (Q4)
-0.44 / -0.54
-0.6314.29% (+0.09)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

PRCT Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Oct 28, 2024$68.77$91.00+32.33%
Aug 01, 2024$62.00$57.38-7.45%
May 01, 2024$52.98$60.61+14.40%
Feb 27, 2024$50.75$49.39-2.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does PROCEPT BioRobotics (PRCT) report earnings?
PROCEPT BioRobotics (PRCT) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
    What is PROCEPT BioRobotics (PRCT) earnings time?
    PROCEPT BioRobotics (PRCT) earnings time is at Mar 04, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PRCT EPS forecast?
          PRCT EPS forecast for the fiscal quarter 2024 (Q4) is -0.34.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis